Rare disease diagnosis remains a key challenge

Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Rare disease diagnosis remains a key challenge

Can we drive a change in perceptions and attitudes by reframing rare diseases and stressing the importance of patient groups?

Alpharmaxim work closely with industry to raise awareness of rare diseases, developing educational materials and resources for healthcare professionals and helping to bring rare diseases into the spotlight.

  • There is an important need for physicians to understand the relevance of rare diseases within their clinical career and to consider rare diseases when the clinical picture doesn’t provide all the answers
  • Further education around genetics and rare diseases for medical students is needed
  • Very few general practitioners have access to rare disease-specific internet resources such as Orphanet; there is limited information regarding when to consider a rare disease and what to do when you come across one in clinical practice

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

Talk to us about how we can transform your communications

Alpharmaxim in the press

Alpharmaxim in the press

With many organisations beginning to invest in behavioural science, we’ve been shouting in the press about the benefits for pharma companies.
Ten ways that internal communications can boost your business

Ten ways that internal communications can boost your business

Employee engagement, brand alignment, sharing expertise to solve problems: these are all things that internal communications can achieve.
It's time for behavioural science to take centre stage in health communications

It's time for behavioural science to take centre stage in health communications

Progress brings new challenges, and help is needed. It might be time for behavioural science to play a bigger part than ever before.